Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Biotech
Cidara regains rights to flu med from Janssen, divests Rezzayo
Cidara already knew that Janssen planned to palm off their flu prophylaxis candidate to another entity. Now, it turns out that entity will be …Cidara.
James Waldron
Apr 24, 2024 4:05pm
GSK, Vir end flu drug alliance, removing key piece of $345M pact
Feb 23, 2024 5:10am
Veru needs cash for fresh trial of respiratory distress drug
Feb 8, 2024 10:45am
GSK tips 12 blockbuster launches to soften HIV patent loss
Jan 31, 2024 7:45am
Would you eat a lollipop without candy? The flu virus won't
Jan 16, 2024 9:02am
Pfizer, BioNTech prep flu-COVID mRNA combo vaccine for phase 3
Oct 26, 2023 9:32am